CSIMarket
 


Vistagen Therapeutics Inc   (VTGN)
Other Ticker:  
 
 

VTGN's Net Cash Flow Growth by Quarter and Year

Vistagen Therapeutics Inc 's Net Cash Flow results by quarter and year




VTGN Net Cash Flow (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter March - -51.50 -15.56 -1.22
III Quarter December 88.95 0.00 -9.93 88.93
II Quarter September 27.99 16.15 -4.15 13.85
I Quarter June -7.02 -16.15 -5.33 0.19
FY   109.92 -51.50 -34.97 101.75



VTGN Net Cash Flow third quarter 2024 Y/Y Growth Comment
Vistagen Therapeutics Inc in the third quarter 2024 achieved Net Cash Flow of $ 88.95 millions compare to net cash outflow recorded in same quarter a year ago.

Looking into third quarter 2024 results within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Net Cash Flow growth. While Vistagen Therapeutics Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 130 in the third quarter 2024.




VTGN Net Cash Flow ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September 73.31 % - - -
I Quarter June - - - -
FY   - - - -

Financial Statements
Vistagen Therapeutics Inc 's third quarter 2024 Net Cash Flow $ 88.95 millions VTGN's Income Statement
Vistagen Therapeutics Inc 's third quarter 2023 Net Cash Flow $ 0.00 millions Quarterly VTGN's Income Statement
New: More VTGN's historic Net Cash Flow Growth >>


VTGN Net Cash Flow (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter March - - - -
III Quarter December 217.79 % - - 542.09 %
II Quarter September - - - 7189.47 %
I Quarter June - - - -34.48 %
FY (Year on Year)   - - - -




Net Cash Flow third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #16
Overall #130

Net Cash Flow Y/Y Growth Statistics
High Average Low
8172.69 % 1562.12 % -100 %
(Dec 31 2017)   (Dec 31 2022)
Net Cash Flow third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #16
Overall #130
Net Cash Flow Y/Y Growth Statistics
High Average Low
8172.69 % 1562.12 % -100 %
(Dec 31 2017)   (Dec 31 2022)

Net Cash Flow by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Vistagen Therapeutics Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
8172.69 % 1562.12 % -100 %
(Dec 31 2017)  


VTGN's III. Quarter Q/Q Net Cash Flow Comment
Vistagen Therapeutics Inc achieved in the III. Quarter 2024 below company average Net Cash Flow doubling of 217.79% quarter on quarter, to $ 88.95 millions.

Even if the III. Quarter 2024 Net Cash Flow Q/Q growth was below the ordinary , that has been yet promising story, as the III. Quarter improvement, transcends the % Net Cash Flow surge in the III. Quarter a year ago

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Vistagen Therapeutics Inc 's Net Cash Flow growth quarter on quarter, overall rank is 130.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #16
Overall #130
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #16
Overall #130
Net Cash Flow Q/Q Growth Statistics
High Average Low
8172.69 % 1562.12 % -100 %
(Dec 31 2017)  


VTGN's III. Quarter Q/Q Net Cash Flow Comment
Vistagen Therapeutics Inc achieved in the III. Quarter 2024 below company average Net Cash Flow doubling of 217.79% quarter on quarter, to $ 88.95 millions.

III. Quarter 2024 Net Cash Flow quarter on quarter growth seem to be paradoxical, even if below the average increase of 1562.12 %, yet it demonstrates real improvement relative to the % in the III. Quarter 2023 Luca  I. Wood, Major Pharmaceutical Preparations industry researcher based in Edinburgh said.

Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Vistagen Therapeutics Inc 's Net Cash Flow growth quarter on quarter, overall rank is 130.


Vistagen Therapeutics Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ 58.42 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment


Vistagen Therapeutics Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment


Vistagen Therapeutics Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
VTGN's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for VTGN's Competitors
Net Cash Flow Growth for Vistagen Therapeutics Inc 's Suppliers
Net Cash Flow Growth for VTGN's Customers

You may also want to know
VTGN's Annual Growth Rates VTGN's Profitability Ratios VTGN's Asset Turnover Ratio VTGN's Dividend Growth
VTGN's Roe VTGN's Valuation Ratios VTGN's Financial Strength Ratios VTGN's Dividend Payout Ratio
VTGN's Roa VTGN's Inventory Turnover Ratio VTGN's Growth Rates VTGN's Dividend Comparisons



Companies with similar Net Cash Flow doubling for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Astrazeneca Plc-5.29%$ -5.287 millions
Lipocine Inc -6.98%$ -6.984 millions
Caredx Inc -14.62%$ -14.617 millions
Sophia Genetics Sa-16.41%$ -16.406 millions
Xencor Inc-17.78%$ -17.780 millions
Kronos Bio Inc -20.78%$ -20.784 millions
Earth Science Tech Inc -21.38%$ -21.381 millions
Hookipa Pharma inc -22.19%$ -22.193 millions
Anaptysbio Inc -24.22%$ -24.222 millions
Koru Medical Systems Inc-26.57%$ -26.570 millions
Abbott Laboratories-35.07%$ -35.069 millions
Lantheus Holdings Inc -37.16%$ -37.161 millions
Alcon inc -37.78%$ -37.778 millions
Inflarx N v -38.04%$ -38.037 millions
Novartis Ag-39.41%$ -39.413 millions
Argenx se-40.00%$ -40.005 millions
Gh Research Plc-40.04%$ -40.040 millions
Bright Minds Biosciences Inc -41.15%$ -41.154 millions
Enzon Pharmaceuticals inc -42.33%$ -42.332 millions
Myriad Genetics Inc -44.65%$ -44.653 millions
Elutia inc -46.46%$ -46.456 millions
Gilead Sciences Inc -46.70%$ -46.704 millions
Koninklijke Philips Nv-49.11%$ -49.110 millions
Avidity Biosciences Inc -49.45%$ -49.449 millions
Proqr Therapeutics N v -49.46%$ -49.460 millions
Protalix Biotherapeutics inc -49.52%$ -49.523 millions
Xeris Biopharma Holdings Inc -49.99%$ -49.994 millions
Altair International Corp -52.34%$ -52.344 millions
Macrogenics Inc -55.57%$ -55.574 millions
Atricure Inc -59.98%$ -59.983 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com